DCVC Opportunity Fund II GP, LLC

In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), DCVC Opportunity Fund II GP, LLC reported 3 stock positions worth $97.4 million. Its top holding was Rocket Lab USA (RKLB) at 72.0% of the portfolio, followed by Recursion Pharmaceuticals-A (RXRX, 26.7%) and Rigetti Computing (RGTI, 1.3%). Its holdings were unchanged from Q2 2024.

Most Recent 13F
Q2 2026
Location
PALO ALTO, CA
CIK
0001668343
Portfolio Value
$97.4M (Q3 2024)
SEC Filing
0001104659-24-118270 ↗ filed Nov 14, 2024

Holdings Value

0$50.0M$100.0M$150.0M Q1 2024: $71.4M Q1 2024 Q2 2024: $65.9M Q2 2024 Q3 2024: $97.4M $97.4M Q3 2024 Q4 2024: $113.0M Q4 2024 Q1 2025: $81.5M Q1 2025 Q2 2025: $115.3M Q2 2025 Q3 2025: $19.3M Q3 2025 Q4 2025: $16.6M Q4 2025 Q1 2026: $13.9M Q1 2026 Q2 2026: $17.2M Q2 2026

Holdings 3 stocks · $97.4M
RKLB Rocket Lab USA Inc. 71.97% 7,203,035 $70.1M No change
RXRX Recursion Pharmaceuticals-A 26.74% 3,951,141 $26.0M No change
RGTI Rigetti Computing Inc. 1.29% 1,599,052 $1.3M No change

Portfolio Sells Q2 2024 → Q3 2024
None this quarter.

Portfolio Buys Q2 2024 → Q3 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 2$17.2MRXRX, IONQ
Q1 2026 2$13.9MRXRX, IONQ
Q4 2025 2$16.6MRXRX, IONQ
Q3 2025 1$19.3MRXRX
Q2 2025 2$115.3MRKLB, RXRX
Q1 2025 2$81.5MRKLB, RXRX
Q4 2024 2$113.0MRKLB, RXRX
Q3 2024 3$97.4MRKLB, RXRX, RGTI
Q2 2024 3$65.9MRKLB, RXRX, RGTI
Q1 2024 3$71.4MRXRX, RKLB, RGTI